Here, GFAP staining revealed a decrease of reactive astrocytes in the hippocampus and the cortex of AD mice treated with PPR@siBACE1 compared to AD mice treated with PP@siBACE1, free siBACE1, or PBS (Fig. 7h, Fig. S17). This evidence concerns the gene GFAP and Alzheimer disease.